Object reference not set to an instance of an object.

Equity capital marketsEquity capital markets

New Zealand's most highly regarded equity capital markets legal team

Chapman Tripp’s national equity capital markets (ECM) team is the largest and most highly regarded in New Zealand with a reputation for acting on the country’s most significant and complex deals.

Our experience ranges across all aspects of ECM transactions including pre-offer structuring, IPOs and secondary capital raisings. Our deep relationships with issuers, lead managers, underwriters, regulators, and government departments and agencies allow us to advise on all securities and capital markets matters – from capital raising to regulation and market supervision.  Chapman Tripp has acted on most of New Zealand’s recent ECM transactions, including acting on 14 (12 as issuer counsel) of the 22 IPOs and NZX Main Board listings in New Zealand since 2013.
 
Chapman Tripp is currently the only law firm accredited to list issuers on the NZX Main Board and the NZX debt market.

Ranked Tier One for capital markets work by independent legal directories IFLR1000 2016 and Asia Law Profiles 2016. 

 

We have advised

  • Arvida Group on its $42m underwritten pro rata rights issue and shortfall book build
  • New Zealand King Salmon on its $77.5m IPO and NZX Main Board and ASX listing
  • G3 Group’s novel equity raising through crowd funding marketplace Snowball Effect, a first for a NZ listed company
  • Moa Group on its underwritten institutional placement and non-renounceable rights issue to raise $4m
  • Goldman Sachs as lead manager and bookrunner on the $185m Investore IPO and NZX Main Board listing
  • Trilogy International on its underwritten $20m placement, $5m share purchase plan, and ASX listing application, and The Business Bakery on its $30m block trade
  • NZME on its NZX Main Board compliance listing, and de-merger from APN News & Media
  • First NZ Capital and Credit Suisse on SKYCITY Entertainment Group’s NZ$263m fully underwritten accelerated renounceable entitlement issue
  • Vista Group International on the NZ$100m sell-down by founder shareholders of part of their escrowed equity.
  • Direct Capital on the sale of its strategic stake in Scales Corporation to China Resources for NZ$60m
  • First NZ Capital as arranger of Wynyard’s $30m rights issue
  • IKEgps on its strategic investor and institutional placement
  • First NZ Capital as sole lead manager of AFT Pharmaceuticals' NZ$40m IPO and NZX Main Board listing
  • Senior Trust Retirement Village Listed Fund on its NZX Main Board listing
  • Wellard on its $A300m IPO and ASX listing extended into New Zealand under the Trans-Tasman mutual recognition regime
  • Snakk Media on its NXT listing and associated capital raising
  • Mercantile Investment Company on its NZX Main Board listing as an Overseas Listed Issuer
  • Property for Industry on its NZ$49.5m underwritten pro rata rights issue
  • Arvida Group on its NZ$30m placement, and NZ$5m Share Purchase Plan, as part of the funding for its NZ$62m acquisition of the Aria retirement villages
  • Deutsche Craigs as bookrunner and underwriter for Chevron New Zealand’s ‘block trade’ sale of its 11.3% stake in The New Zealand Refining Company for NZ$82m
  • First NZ Capital underwriter of Pacific Edge’s NZ$35m rights issue
  • G3 Group on its NZ$40m compliance listing, the first company to list on NZX’s new NXT market
  • First NZ Capital and Credit Suisse (Australia) as underwriters of Kiwi Property Group’s NZ$152m accelerated renounceable entitlement issue
  • Deutsche Craigs as underwriter and arranger of  AWF Group's NZ$14m rights issue
  • First NZ Capital and Credit Suisse (Australia) as underwriters of Precinct Properties’ NZ$174m accelerated renounceable entitlement issue
  • Arvida Group on all aspects of its 2014 NZ$80m IPO and NZX Main Board listing, in conjunction with an acquisition of 17 aged care facilities for scrip for a deal value of NZ$329m
  • First NZ Capital and Deutsche Craigs on the NZ$125m IPO and NZX Main Board listing of Orion Health
  • Moa Group’s placement and rights issue, under the new ‘same class quoted offer’ regime
  • EROAD’s NZ$46m IPO and NZX Main Board listing
  • Vista Group International’s NZ$92.5m IPO and NZX and ASX listing
  • Scales Corporation on its NZ$149m IPO and NZX Main Board listing
  • ikeGPS on its NZ$25m IPO and NZX Main Board listing
  • ASX-listed Arowana International on the IPO of its Australasian education business, Intueri Education Group. In connection with the IPO, Intueri Education Group has listed on both the NZX Main Board and the ASX. The IPO values Intueri Education Group at NZ$235m
  • The Treasury on all aspects of the IPO and NZX and ASX listing of 49% of Genesis Energy, which raised NZ$733m. It was the final sale in the Government's Mixed Ownership Model (MOM) programme
  • Aviation services provider Airwork Holdings on its NZ$40m IPO and NZX Main Board listing
  • The Treasury on all aspects of the Crown's $365m partial sell down of its majority stake in national airline Air New Zealand
  • petroleum distributor and retailer Z Energy, and its shareholders Infratil and the New Zealand Superannuation Fund, on all aspects of its NZ$840m partial IPO and associated NZX and ASX listings
  • Mighty River Power on all aspects of its 2013 IPO and NZX and ASX listing, which valued the company at NZ$3.5b

Initial contacts

    Services